1r5i

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1r5i" size="450" color="white" frame="true" align="right" spinBox="true" caption="1r5i, resolution 2.60&Aring;" /> '''Crystal structure o...)
Line 1: Line 1:
-
[[Image:1r5i.gif|left|200px]]<br />
+
[[Image:1r5i.gif|left|200px]]<br /><applet load="1r5i" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1r5i" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1r5i, resolution 2.60&Aring;" />
caption="1r5i, resolution 2.60&Aring;" />
'''Crystal structure of the MAM-MHC complex'''<br />
'''Crystal structure of the MAM-MHC complex'''<br />
==Overview==
==Overview==
-
Mycoplasma arthritidis-derived mitogen (MAM) is a superantigen that can, activate large fractions of T cells bearing particular TCR Vbeta elements., Here we report the crystal structure of MAM complexed with a major, histocompatibility complex (MHC) antigen, HLA-DR1, loaded with, haemagglutinin peptide 306-318 (HA). The structure reveals that MAM has a, novel fold composed of two alpha-helical domains. This fold is entirely, different from that of the pyrogenic superantigens, consisting of a, beta-grasped motif and a beta barrel. In the complex, the N-terminal, domain of MAM binds orthogonally to the MHC alpha1 domain and the bound HA, peptide, and to a lesser extent to the MHC beta1 domain. Two MAM molecules, form an asymmetric dimer and cross-link two MHC antigens to form a, plausible, dimerized MAM-MHC complex. These data provide the first, crystallographic evidence that superantigens can dimerize MHC molecules., Based on our structure, a model of the TCR2MAM2MHC2 complex is proposed.
+
Mycoplasma arthritidis-derived mitogen (MAM) is a superantigen that can activate large fractions of T cells bearing particular TCR Vbeta elements. Here we report the crystal structure of MAM complexed with a major histocompatibility complex (MHC) antigen, HLA-DR1, loaded with haemagglutinin peptide 306-318 (HA). The structure reveals that MAM has a novel fold composed of two alpha-helical domains. This fold is entirely different from that of the pyrogenic superantigens, consisting of a beta-grasped motif and a beta barrel. In the complex, the N-terminal domain of MAM binds orthogonally to the MHC alpha1 domain and the bound HA peptide, and to a lesser extent to the MHC beta1 domain. Two MAM molecules form an asymmetric dimer and cross-link two MHC antigens to form a plausible, dimerized MAM-MHC complex. These data provide the first crystallographic evidence that superantigens can dimerize MHC molecules. Based on our structure, a model of the TCR2MAM2MHC2 complex is proposed.
==About this Structure==
==About this Structure==
-
1R5I is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [http://en.wikipedia.org/wiki/Mycoplasma_arthritidis Mycoplasma arthritidis] with PO4 as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1R5I OCA].
+
1R5I is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [http://en.wikipedia.org/wiki/Mycoplasma_arthritidis Mycoplasma arthritidis] with <scene name='pdbligand=PO4:'>PO4</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1R5I OCA].
==Reference==
==Reference==
Line 15: Line 14:
[[Category: Mycoplasma arthritidis]]
[[Category: Mycoplasma arthritidis]]
[[Category: Protein complex]]
[[Category: Protein complex]]
-
[[Category: Drozd, S.J.]]
+
[[Category: Drozd, S J.]]
[[Category: Guo, Y.]]
[[Category: Guo, Y.]]
[[Category: Li, H.]]
[[Category: Li, H.]]
Line 27: Line 26:
[[Category: superantigen]]
[[Category: superantigen]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 19:00:25 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:47:17 2008''

Revision as of 12:47, 21 February 2008

Image:1r5i.gif

1r5i, resolution 2.60Å

Drag the structure with the mouse to rotate

Crystal structure of the MAM-MHC complex

Overview

Mycoplasma arthritidis-derived mitogen (MAM) is a superantigen that can activate large fractions of T cells bearing particular TCR Vbeta elements. Here we report the crystal structure of MAM complexed with a major histocompatibility complex (MHC) antigen, HLA-DR1, loaded with haemagglutinin peptide 306-318 (HA). The structure reveals that MAM has a novel fold composed of two alpha-helical domains. This fold is entirely different from that of the pyrogenic superantigens, consisting of a beta-grasped motif and a beta barrel. In the complex, the N-terminal domain of MAM binds orthogonally to the MHC alpha1 domain and the bound HA peptide, and to a lesser extent to the MHC beta1 domain. Two MAM molecules form an asymmetric dimer and cross-link two MHC antigens to form a plausible, dimerized MAM-MHC complex. These data provide the first crystallographic evidence that superantigens can dimerize MHC molecules. Based on our structure, a model of the TCR2MAM2MHC2 complex is proposed.

About this Structure

1R5I is a Protein complex structure of sequences from Homo sapiens and Mycoplasma arthritidis with as ligand. Full crystallographic information is available from OCA.

Reference

Crystal structure of Mycoplasma arthritidis mitogen complexed with HLA-DR1 reveals a novel superantigen fold and a dimerized superantigen-MHC complex., Zhao Y, Li Z, Drozd SJ, Guo Y, Mourad W, Li H, Structure. 2004 Feb;12(2):277-88. PMID:14962388

Page seeded by OCA on Thu Feb 21 14:47:17 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1r5i"
Personal tools